A review of six placebo-controlled medical trials with 1,134 whole members concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) have been connected with a higher average advancement over the Ashworth scale for spasticity in many sclerosis sufferers in comparison with placebo, Though this did not reach statistical importance. Determined by two https://johnl295idx5.wikissl.com/user